Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 36 (RN7SKP36) is annotated as a **pseudogene** of RN7SK, meaning it is a nonfunctional genomic locus derived from the RN7SK gene, which encodes a long non-coding RNA involved in transcriptional regulation. Unlike its parent gene RN7SK, which has a clear role as part of the 7SK snRNP complex regulating RNA polymerase II and cell proliferation/differentiation, **RN7SKP36 does not produce a functional RNA or protein** and is not known to be expressed or associated with any biological activity, disease, or drug interaction. Pseudogenes, including those of non-coding RNAs, are generally not considered drug targets, diagnostic biomarkers, or of direct biological interest unless new evidence shows a gain-of-function or regulatory activity, which is not reported for RN7SKP36 based on current knowledge.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 36 (RN7SKP36).